Displaying one Session

Clinical Focus Session
Moderator/s:
  • J. Ricke (Munich, DE)
  • B. Sangro (Pamplona, ES)
Date:
Sat, Apr 10, 2021
Time (in CEST):
14:30 - 16:00

402.1 - Biology of HCC as a driver for decision making

Presenter:
  • P. Schirmacher (Heidelberg, DE)
Learning Objectives:
1. To learn about the recommendations for HCC biopsy
2. To understand the benefits of widespread use of biopsy in HCC (immune infiltration, prognostic factors)
3. To understand the impact of biopsy on decision making

402.2 - Ablation: pushing the frontiers

EBIR
Yes
Presenter:
  • L. Crocetti (Pisa, IT)
Learning Objectives:

1. To learn from new ablation therapies
2. To learn from combined therapies with ablation
3. To learn about the current clinical results and future perspectives

402.3 - Bridging to transplantation: what are the best solutions?

Presenter:
  • R. García-Mónaco (Buenos Aires, AR)
Learning Objectives:

1. To understand a comprehensive review of patient selection for bridging to transplantation
2. To learn the different outcomes for bridging versus no bridging before transplantation
3. To learn the best therapeutic option and comparative clinical results including resection

402.4 - What could be the role of SBRT and proton in HCC?

Presenter:
  • J. Debus (Heidelberg, DE)
Learning Objectives:
1. To understand the principles and prerequisites of radiation oncology in HCC
2. To learn about the current clinical results in early and intermediate HCC
3. To learn the limitations and complications of radiation oncology in HCC

402.5 - When to switch from local to systemic therapy

EBIR
Yes
Presenter:
  • A. Vogel (Hannover, DE)
Learning Objectives:
1. To learn the different pathways of systemic treatments
2. To understand the selection criteria for switching to systemic therapies
3. To learn which systemic treatment may be recommended in this clinical situation

402.6 - The role of IR in advanced HCC

Presenter:
  • T. De Baère (Villejuif, FR)
Learning Objectives:
1. To learn different clinical situations summarised in "advanced HCC"
2. To understand a comprehensive review of patient selection
3. To learn clinical results in comparison with standard therapies